Sarcoma biology and outcomes registry
Part of Cancer clinical trials.
This trial is a health registry that collects information about people with soft-tissue or bone sarcoma. It helps researchers understand how the disease behaves and what outcomes different treatments lead to.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed diagnosis of soft-tissue or bone sarcoma
- You are at least 12 years old
- You can understand what the study involves and its personal impact
- You can provide written consent (or have the legally appropriate process for consent)
- You are physically and mentally able to complete the consent process
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a German “registry,” meaning it collects information about people with specific bone or soft tissue tumors (including some borderline or hard-to-classify cases). It helps doctors and researchers learn more about these rare conditions to improve future care.
This trial tests a way to use patient information to help doctors decide which treatment approach may fit best for people with certain bone or soft-tissue tumors. It may help improve selection and care planning, but it depends on whether your data can be used.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This study gathers information from people diagnosed with sarcoma (a bone or soft-tissue cancer) and their family members to learn what life is like after diagnosis. It is open to patients of any age, as well as their parents, caregivers, and older siblings.
This trial tests a precision medicine approach by giving targeted therapy before surgery for high-risk soft tissue sarcoma. The goal is to see if matching treatment to your tumor's type can improve outcomes.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.